Discovery Programs

Partnerships

Gubra is well-known as a professional and strong scientific collaboration partner. Our agile data-driven approach is highly valued by our partners and is key to our success. We dedicate great attention and resources to each partnership, and we are always open for new collaboration opportunities.

Why choose Gubra?

Trusted collaboration partner
Extensive scientific knowledge
One-team approach to partnerships
Professional & agile project organization
High quality & rapid data delivery

Consult with Lise Biehl Rudkjær

Director, Business Development

Choose the right, trustworthy discovery partner.

Our Areas of Expertise

Disease
Focus Areas

Metabolism, fibrosis and inflammation
NASH, obesity, renal and cardiovascular diseases
Inflammatory Bowel Disease (IBD)
Idiopathic pulmonary fibrosis (IPF)

Peptide
Drug Discovery

All types of peptide molecules
Rapid peptide synthesis – up to 4000 peptides/month
Unbiased and systematic approach through streaMLine platform
Peptide hit to develop into a clinical candidate

Target
Discovery

All types of targets
Advanced data-driven approach through PreDict platform
Rapid In Vivo validation and Proof of Concept
Flexible inter-organ approach

How we work

Diverse collaborations

We collaborate with pharmaceutical and biotech companies and leading academic institutions. We are a trusted, competent partner in the discovery and preclinical space, and early clinical development.

One-team or joint efforts

We can work with your scientists as one team, or you can guide us as an external independent biotech group. You can choose what is best suited for your project.

Flexible approach to deal making

We recognize that every partner and program is unique and we take a pragmatic approach to deal making. The goal is to provide benefits for all parties with creative solutions.